ArticleBritish journal of biomedical science2026
Correlation between oxidative stress and inflammation with metabolomics profile in skeletal muscle of ageing animal model and its modulation by tocotrienol-rich fraction.
Article in British journal of biomedical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Turnera diffusa polysaccharides promote healthy aging through conserved stress response regulation and metabolic remodeling across multiple aging models.Biogerontology · 2026Article
- Antioxidant Interventions on Muscle Function and Mass in Aging-Related Muscle Decline: A Systematic Review of Preclinical and Clinical Evidence.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sarcopenia, characterised by age-associated decline in skeletal muscle mass and function, is driven by multifactorial mechanisms including oxidative stress, chronic inflammation, and genomic instability. The imbalance between reactive oxygen species (ROS) and antioxidant defence contributes to mitochondrial dysfunction and DNA damage, thereby affecting cellular metabolism and promoting muscle degeneration. Tocotrienol-rich fraction (TRF), a potent antioxidant form of vitamin E, has shown potential in modulating oxidative and inflammatory pathways. However, Methods: Young (3 months) and old (21 months) male Sprague-Dawley rats were divided into control and TRF-supplemented groups (n = 10). TRF was administered orally (60 mg/kg/day) for 3 months. Antioxidant enzymes, lipid peroxidation products: malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE); and inflammatory markers: C-reactive protein (CRP), Interleukin-6 (IL-6), and tumour necrosis factor alpha (TNF-α) were quantified, alongside DNA damage, using the comet assay. Muscle histology was assessed using hematoxylin and eosin (H&E) staining. Pearson correlation analysis was performed between selected metabolites and biological markers. Results: Ageing significantly increased oxidative damage, pro-inflammatory markers, and DNA fragmentation, while reducing antioxidant enzyme activities and disrupting metabolic profiles. Although TRF supplementation did not significantly restore muscle mass or overall body composition, it effectively enhanced antioxidant defence by increasing Superoxide dismutase (SOD) and catalase (CAT) activities, reducing lipid peroxidation (MDA and 4-HNE), attenuating inflammatory responses, preserving DNA integrity, and improving muscle histological features. Importantly, correlation analyses revealed that ageing is associated with a coordinated metabolic shift linking amino acid and carnitine metabolism with antioxidant defence, inflammation, and genomic stability. TRF supplementation weakened these maladaptive biomarker and metabolite associations while strengthening correlations between protective metabolites (e.g., taurine, histidine, pantothenic acid) and antioxidant enzymes, alongside inverse relationships between lipid peroxidation and inflammatory markers (e.g., MDA, prostaglandin factor 2-alpha, PGF2α) and redox-supportive metabolites. Discussion: Collectively, these findings indicate that TRF acts primarily as a preventive intervention by restoring redox balance, dampening inflammatory signalling, and stabilising metabolic and inflammatory coupling, highlighting its potential as a nutritional strategy for preserving muscle health and genomic integrity during ageing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.